Fermented chrysanthemum stems and leaves support intestinal health by modulating gut microbiota and barrier function in a DSS-induced colitis model
Journal of Functional Foods · 2026-06 · 141 · 107323
DOI: 10.1016/j.jff.2026.107323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2026-06. Verfasst von Ying Qian und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Agriculture and Rural Affairs of the People's Republic of China, National Natural Science Foundation of China, Government of Jiangsu Province.
Abstract (Originalsprache)
Chrysanthemum stems and leaves are abundant agricultural byproducts that remain underutilized despite their rich phytochemical composition. In this study, a food-grade fermentation strategy using Ligilactobacillus plantarum was applied to enhance the intestinal health–supporting potential of chrysanthemum stems and leaves. Fermentation-induced compositional changes were characterized by UPLC–MS–based metabolomics, and the functional effects of the fermented product (FCSL) were evaluated in a dextran sulfate sodium (DSS)-induced colitis mouse model.Metabolomic analysis revealed significant changes in the phytochemical profile of chrysanthemum stems and leaves, particularly in flavonoids and phenolic acids. Dietary supplementation with FCSL alleviated DSS-associated intestinal injury, as evidenced by reduced disease activity index, attenuation of colon shortening, and improved histopathological features. These effects were associated with modulation of inflammatory responses, including reduced pro-inflammatory cytokines and increased IL-10 expression.FCSL supplementation preserved goblet cell abundance, upregulated MUC2 expression, and enhanced intestinal barrier integrity through increased expression of tight junction proteins. Gut microbiota analysis demonstrated that FCSL reshaped microbial community composition, characterized by enrichment of Ligilactobacillus and reduced abundance of Prevotella . Fecal microbiota transplantation further supported a contributory role of microbiota modulation in the observed intestinal benefits. In addition, fecal metabolomic analysis indicated partial normalization of DSS-associated metabolic disturbances, particularly in lipid metabolism pathways. Overall, these findings demonstrate that lactic acid bacteria fermentation is a promising strategy to enhance the functional value of chrysanthemum stem–leaf biomass, supporting its potential as a functional food ingredient for intestinal health and sustainable agricultural byproduct utilization.
Förderung
- Ministry of Agriculture and Rural Affairs of the People's Republic of China
- National Natural Science Foundation of China
- Government of Jiangsu Province
- National Key Research and Development Program of China
Zitieren
APA
Qian, Y., Jiang, X., Jiang, L., Cheng, F., Qu, M., Wei, K., Yao, W., Zhang, L., Gao, M., Yan, H., & Chen, P. (2026). Fermented chrysanthemum stems and leaves support intestinal health by modulating gut microbiota and barrier function in a DSS-induced colitis model. Journal of Functional Foods, 141, 107323. https://doi.org/10.1016/j.jff.2026.107323
Vancouver
Qian Y, Jiang X, Jiang L, Cheng F, Qu M, Wei K, et al. Fermented chrysanthemum stems and leaves support intestinal health by modulating gut microbiota and barrier function in a DSS-induced colitis model. Journal of Functional Foods. 2026;141:107323. doi:10.1016/j.jff.2026.107323
BibTeX
@article{Qian2026,
author = {Qian, Ying and Jiang, Xuan and Jiang, Lejing and Cheng, Fangfang and Qu, Minye and Wei, Kaifeng and Yao, Weifeng and Zhang, Li and Gao, Mingliang and Yan, Hui and Chen, Peidong},
title = {Fermented chrysanthemum stems and leaves support intestinal health by modulating gut microbiota and barrier function in a DSS-induced colitis model},
journal = {Journal of Functional Foods},
year = {2026},
volume = {141},
pages = {107323},
doi = {10.1016/j.jff.2026.107323}
}
EUVIMED